Cognition Therapeutics
CGTX
CGTX
35 hedge funds and large institutions have $13M invested in Cognition Therapeutics in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $13.8M → $13M (-$812K)
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$167K | |
| 2 | +$114K | |
| 3 | +$53K | |
| 4 |
BlackRock
New York
|
+$43.8K |
| 5 |
Bank of New York Mellon
New York
|
+$37.7K |
Top Sellers
| 1 | -$211K | |
| 2 | -$160K | |
| 3 | -$84.2K | |
| 4 |
Two Sigma Investments
New York
|
-$55.9K |
| 5 |
Neuberger Berman Group
New York
|
-$31.4K |